Trials / Completed
CompletedNCT03395548
Stability of the Microbiome in IBD and IBS
Stability of the Intestinal Microbiome in Patients Suffering From Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS) Under the Influence of an Osmotic Laxans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
In this study the investigators aim to investigate the changes of the intestinal microbiome in three different cohorts (IBD, IBS, healthy) after applying the uniform disruptive factor of osmotic diarrhea induced by macrogol. The investigators hypothesis is that ill people will show more severe changes of the microbiome than healthy people and that these changes persist longer.
Detailed description
I
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Macrogol | Used drug: Macrogol (osmotic laxative) |
Timeline
- Start date
- 2017-08-25
- Primary completion
- 2020-05-01
- Completion
- 2020-05-01
- First posted
- 2018-01-10
- Last updated
- 2020-08-11
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT03395548. Inclusion in this directory is not an endorsement.